M&B Sciences recently acquired Clara Health, and its innovative patient recruitment and retention technology platform has greatly enhanced our ability to bring decentralized and hybrid trial technology tools to our clients while still maintaining our core values of ensuring patient centricity and diversity within clinical trials.